Skip to main content
Top
Published in: Calcified Tissue International 3/2005

01-09-2005

Genetic Polymorphisms of OPG, RANK, and ESR1 and Bone Mineral Density in Korean Postmenopausal Women

Authors: J. Y. Choi, A. Shin, S. K. Park, H. W. Chung, S.I. Cho, C. S. Shin, H. Kim, K. M. Lee, K. H. Lee, C. Kang, D. Y. Cho, D. Kang

Published in: Calcified Tissue International | Issue 3/2005

Login to get access

Abstract

To evaluate the effects of genetic polymorphisms of OPG, RANK, and ESR1, which regulate osteoclastogenesis, on bone mineral density (BMD), a cross-sectional study was conducted in 650 Korean postmenopausal women. BMDs of the distal radius and the calcaneus were measured by dual energy X-ray absorptiometry (DXA). Genetic polymorphisms of OPG 163 A > G, 1181 G > C; RANK 421 C > T, 575 T > C; and ESR1 1335 C > T, 2142 G > A were determined by matrix-assisted laser desorption/ionization—time of flight (MALDI-ToF) mass spectrometry. The differences between the BMDs of the genotypes of OPG, RANK, and ESR1 were analyzed by multiple linear regression model adjusted for age and body mass index. Women with the OPG 1181 CC genotype had higher BMDs at the distal radius (7%) and calcaneus (10%) than those with the GG genotype; and these differences were statistically significant (P = 0.001 and P = 0.007, respectively). A significant association was also observed between RANK 575 T > C and calcaneus BMD (P for trend = 0.017). No significant association was observed between BMDs and the polymorphisms of ESR1. The association between OPG 1181 G > C and BMD was profound in subjects with the RANK 575 TT or ESR1 2142 GG genotypes; women with OPG 1181 CC had higher BMDs at the distal radius (11%) and calcaneus (11%) than those with OPG 1181 GG only in women with RANK 575 TT genotype (P = 0.002 and P = 0.021, respectively). These results suggest that OPG genetic polymorphisms, especially with the RANK 575 TT or ESR1 2142 GG genotypes, are related to low BMD in postmenopausal Korean women.
Appendix
Available only for authorised users
Literature
1.
go back to reference NIH consensus conference (2001) Osteoporosis prevention, diagnosis, and therapy. J Am Med Assoc 285:785–795 NIH consensus conference (2001) Osteoporosis prevention, diagnosis, and therapy. J Am Med Assoc 285:785–795
2.
go back to reference Ammann P, Rizzoli R (2003) Bone strength and its determinants. Osteoporosis Int 14(Suppl 3):S13–S18CrossRef Ammann P, Rizzoli R (2003) Bone strength and its determinants. Osteoporosis Int 14(Suppl 3):S13–S18CrossRef
4.
go back to reference Ralston SH (2002) Genetic control of susceptibility to Osteoporosis. J Clin Endocr Metab 87:2460–2466CrossRefPubMed Ralston SH (2002) Genetic control of susceptibility to Osteoporosis. J Clin Endocr Metab 87:2460–2466CrossRefPubMed
5.
go back to reference Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638–649CrossRefPubMed Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638–649CrossRefPubMed
6.
go back to reference Aubin JE, Bonnelye E (2000) Osteopretegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporosis Int 11:905–913CrossRef Aubin JE, Bonnelye E (2000) Osteopretegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporosis Int 11:905–913CrossRef
7.
go back to reference Khosia S, Melton LJ, Riggs BL (2002) Estrogen and the male skeleton. J Clin Endocr Metab 87:1443–1450CrossRefPubMed Khosia S, Melton LJ, Riggs BL (2002) Estrogen and the male skeleton. J Clin Endocr Metab 87:1443–1450CrossRefPubMed
8.
go back to reference Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL (1999) Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140:4367–4370CrossRefPubMed Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL (1999) Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140:4367–4370CrossRefPubMed
9.
go back to reference Shevde NK, Bendixen AC, Dienger KM, Pike JW (2000) Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 97:7828–7834CrossRef Shevde NK, Bendixen AC, Dienger KM, Pike JW (2000) Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 97:7828–7834CrossRef
10.
go back to reference Saika M, Inoue D, Kido S, Matsumoto T (2001) 17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha. Endocrinology 142:2205–2212CrossRefPubMed Saika M, Inoue D, Kido S, Matsumoto T (2001) 17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha. Endocrinology 142:2205–2212CrossRefPubMed
11.
go back to reference Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:1221–1230CrossRefPubMed Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL (2003) Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:1221–1230CrossRefPubMed
12.
go back to reference Arko B, Prezelj J, Komel R, Kocijancic A, Marc J (2002) Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. J Clin Endocr Metab 87:4080–4084CrossRefPubMed Arko B, Prezelj J, Komel R, Kocijancic A, Marc J (2002) Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. J Clin Endocr Metab 87:4080–4084CrossRefPubMed
13.
go back to reference Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF (2002) Polymorphisms in the osteoprotegrin gene are associated with osteoporotic fractures. J Bone Miner Res 17:1245–1255PubMed Langdahl BL, Carstens M, Stenkjaer L, Eriksen EF (2002) Polymorphisms in the osteoprotegrin gene are associated with osteoporotic fractures. J Bone Miner Res 17:1245–1255PubMed
14.
go back to reference Ohmori H, Makita Y, Funamizu K, Hirooka K, Hosoi T, Orimo H, Suzuki T, Ikari K, Nakajima T, Inoue I, Hata A (2000) Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis. J Hum Genet 47:400–406CrossRef Ohmori H, Makita Y, Funamizu K, Hirooka K, Hosoi T, Orimo H, Suzuki T, Ikari K, Nakajima T, Inoue I, Hata A (2000) Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis. J Hum Genet 47:400–406CrossRef
15.
go back to reference Wynne F, Drummond F, O’Sullivan K, Daly M, Shanahan F, Molloy MG, Quane KA (2002) Investigation of the genetic influence of the OPG, VDR (FokI), and COL1A1 Sp1 polymorphisms on BMD in the Irish population. Calcif Tissue Int 71:26–35CrossRefPubMed Wynne F, Drummond F, O’Sullivan K, Daly M, Shanahan F, Molloy MG, Quane KA (2002) Investigation of the genetic influence of the OPG, VDR (FokI), and COL1A1 Sp1 polymorphisms on BMD in the Irish population. Calcif Tissue Int 71:26–35CrossRefPubMed
16.
go back to reference Yamada Y, Ando F, Niino N, Shimokata H (2003) Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. Molec Genet Metab 80:344–349CrossRef Yamada Y, Ando F, Niino N, Shimokata H (2003) Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. Molec Genet Metab 80:344–349CrossRef
17.
go back to reference Brandstrom H, Gerdhem P, Stiger F, Obrant KJ, Melhus H, Ljunggren O, Kindmark A, Akesson K (2004) Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women. Calcif Tissue Int 74:18–24CrossRefPubMed Brandstrom H, Gerdhem P, Stiger F, Obrant KJ, Melhus H, Ljunggren O, Kindmark A, Akesson K (2004) Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women. Calcif Tissue Int 74:18–24CrossRefPubMed
18.
go back to reference Jorgensen HL, Kusk P, Madsen B, Fenger M, Lauritzen J (2004) Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios. J Bone Miner Metab 22:132–138CrossRefPubMed Jorgensen HL, Kusk P, Madsen B, Fenger M, Lauritzen J (2004) Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios. J Bone Miner Metab 22:132–138CrossRefPubMed
19.
go back to reference Wuyts W, Van Wesenbeeck L, Morales-Piga A, Ralston S, Hocking L, Vanhoenacker F, Westhovens R, Verbruggen L, Anderson D, Hughes A, Van Hul W (2001) Evaluation of the role of RANK and OPG genes in Paget’s disease of bone. Bone 28:104–107CrossRefPubMed Wuyts W, Van Wesenbeeck L, Morales-Piga A, Ralston S, Hocking L, Vanhoenacker F, Westhovens R, Verbruggen L, Anderson D, Hughes A, Van Hul W (2001) Evaluation of the role of RANK and OPG genes in Paget’s disease of bone. Bone 28:104–107CrossRefPubMed
20.
go back to reference Ioannidis JP, Stavrou I, Trikalinos TA, Zois C, Brandi ML, Gennari L, Albagha O, Ralston SH, Tsatsoulis A (2002) Association of polymorphisms of the estrogen receptor α gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res 17:2048–2060PubMed Ioannidis JP, Stavrou I, Trikalinos TA, Zois C, Brandi ML, Gennari L, Albagha O, Ralston SH, Tsatsoulis A (2002) Association of polymorphisms of the estrogen receptor α gene with bone mineral density and fracture risk in women: a meta-analysis. J Bone Miner Res 17:2048–2060PubMed
21.
go back to reference Han K, Choi J, Moon I, Yoon H, Han I, Min H, Kirn Y, Choi Y (1999) Non-association of estrogen receptor genotypes with bone mineral density and bone turnover in Korean pre-, peri-, and postmenopausal women. Osteoporosis Int 9:290–295CrossRef Han K, Choi J, Moon I, Yoon H, Han I, Min H, Kirn Y, Choi Y (1999) Non-association of estrogen receptor genotypes with bone mineral density and bone turnover in Korean pre-, peri-, and postmenopausal women. Osteoporosis Int 9:290–295CrossRef
22.
go back to reference Kim JG, Lim KS, Kim EK, Choi YM, Lee JY (2001) Association of vitamin D receptor and estrogen receptor gene polymorphisms with bone mass in postmenopausal Korean women. Menopause 8:222–228CrossRefPubMed Kim JG, Lim KS, Kim EK, Choi YM, Lee JY (2001) Association of vitamin D receptor and estrogen receptor gene polymorphisms with bone mass in postmenopausal Korean women. Menopause 8:222–228CrossRefPubMed
23.
go back to reference Ioannidis JPA, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB, Langdahl B, van Meurs JB, Mosekilde L, Scollen S, Albagha OME, Bustamante M, Carey AH, Dunning AM, Enjuanes A, van Leeuwen JPTM, Mavilia C, Masi L, McGuigan FEA, Nogues X, Pols HAP, Reid DM, Schuit SCE, Sherlock RE, Uitterlinden AG (2004) Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292:2105–2114CrossRefPubMed Ioannidis JPA, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB, Langdahl B, van Meurs JB, Mosekilde L, Scollen S, Albagha OME, Bustamante M, Carey AH, Dunning AM, Enjuanes A, van Leeuwen JPTM, Mavilia C, Masi L, McGuigan FEA, Nogues X, Pols HAP, Reid DM, Schuit SCE, Sherlock RE, Uitterlinden AG (2004) Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA 292:2105–2114CrossRefPubMed
24.
go back to reference Jurada S, Marc J, Prezelj J, Kocijancic A, Komel R (2001) Codon 325 sequence polymorphism of the estrogen receptor gene and bone mineral density in postmenopausal women. J Steroid Biochem 78:15–20CrossRef Jurada S, Marc J, Prezelj J, Kocijancic A, Komel R (2001) Codon 325 sequence polymorphism of the estrogen receptor gene and bone mineral density in postmenopausal women. J Steroid Biochem 78:15–20CrossRef
25.
go back to reference Ongphiphadhanakul B, Chanprasertyothin S, Payattikul P, Saetung S, Piaseu N, Chailurkit L, Rajatanavin R (2001) Association of a G2014A transition in exon 8 of estrogen receptor-α gene with postmenopausal osteoporosis. Osteoporosis Int 12:1015–1019CrossRef Ongphiphadhanakul B, Chanprasertyothin S, Payattikul P, Saetung S, Piaseu N, Chailurkit L, Rajatanavin R (2001) Association of a G2014A transition in exon 8 of estrogen receptor-α gene with postmenopausal osteoporosis. Osteoporosis Int 12:1015–1019CrossRef
26.
go back to reference Hoshino S, Hosoi T, Miyao M, Shiraki M, Orimo H, Ouchi Y, Inoue S (2000) Identification of a novel polymorphism of estrogen receptor-α gene that is associated with calcium excretion in urine. J Bone Miner Metab 18:153–157CrossRefPubMed Hoshino S, Hosoi T, Miyao M, Shiraki M, Orimo H, Ouchi Y, Inoue S (2000) Identification of a novel polymorphism of estrogen receptor-α gene that is associated with calcium excretion in urine. J Bone Miner Metab 18:153–157CrossRefPubMed
27.
go back to reference Shin A, Choi JY, Chung HW, Park SK, Shin CS, Choi YH, Cho SI, Kim DS, Kim DI, Lee KM, Lee KH, Yoo KY, Kang D (2004) Prevalence and risk factors of distal forearm and calcaneus bone mineral density in Korean population. Osteoporosis Int 15: 639–644CrossRef Shin A, Choi JY, Chung HW, Park SK, Shin CS, Choi YH, Cho SI, Kim DS, Kim DI, Lee KM, Lee KH, Yoo KY, Kang D (2004) Prevalence and risk factors of distal forearm and calcaneus bone mineral density in Korean population. Osteoporosis Int 15: 639–644CrossRef
28.
go back to reference Shepherd JA, Cheng XG, Lu Y, Njeh C, Toschke J, Engelke K, Grigorian M, Genant HK (2002) Universal standardization of forearm bone densitometry. J Bone Miner Res 17:734–745PubMed Shepherd JA, Cheng XG, Lu Y, Njeh C, Toschke J, Engelke K, Grigorian M, Genant HK (2002) Universal standardization of forearm bone densitometry. J Bone Miner Res 17:734–745PubMed
29.
go back to reference Stephens M, Donnelly P (2003) A comparison of Bayesian methods for haplotype reconstruction. Am J Hum Genet 73:1162–1169CrossRefPubMed Stephens M, Donnelly P (2003) A comparison of Bayesian methods for haplotype reconstruction. Am J Hum Genet 73:1162–1169CrossRefPubMed
30.
go back to reference Lewontin RC (1988) On measures of gametic disequilibrium. Genetics 120:849–852PubMed Lewontin RC (1988) On measures of gametic disequilibrium. Genetics 120:849–852PubMed
31.
go back to reference Uitterlinden AG, Weel AEAM, Burger H, Fang Y, van Duijn CM, Hofman A, van Leeuwen JPTM, Pols HAP (2001) Interaction between the vitatmin D receptor gene and collagen type Iα1 gene in susceptibility of fracture. J Bone Miner Res 16:379–385PubMed Uitterlinden AG, Weel AEAM, Burger H, Fang Y, van Duijn CM, Hofman A, van Leeuwen JPTM, Pols HAP (2001) Interaction between the vitatmin D receptor gene and collagen type Iα1 gene in susceptibility of fracture. J Bone Miner Res 16:379–385PubMed
32.
go back to reference Colin EM, Uitterlinden AG, Meurs JBJ, Bergink AP, van de Klift M, Fang Y, Arp PP, Hofman A, van Leeuwen JPTM, Pols HAP (2003) Interaction between vitamin D receptor genotype and estrogen receptor α genotype influences vertebral fracture risk. J Clin Endocrinol Metab 88:3777–3784CrossRefPubMed Colin EM, Uitterlinden AG, Meurs JBJ, Bergink AP, van de Klift M, Fang Y, Arp PP, Hofman A, van Leeuwen JPTM, Pols HAP (2003) Interaction between vitamin D receptor genotype and estrogen receptor α genotype influences vertebral fracture risk. J Clin Endocrinol Metab 88:3777–3784CrossRefPubMed
33.
go back to reference Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner W, Nevitt M, Cummings SR (2003) BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res 18:1947–1954PubMed Stone KL, Seeley DG, Lui LY, Cauley JA, Ensrud K, Browner W, Nevitt M, Cummings SR (2003) BMD at multiple sites and risk of fracture of multiple types: long-term results from the study of osteoporotic fractures. J Bone Miner Res 18:1947–1954PubMed
34.
go back to reference Sweeney AT, Malabanan AO, Blake MA, Weinberg J, Turner A, Ray P, Holick MF (2002) Bone mineral density assessment: comparison of dual-energy X-ray absorptiometry measurements at the calcaneus, spine, and hip. J Clin Densitom 5:57–62CrossRefPubMed Sweeney AT, Malabanan AO, Blake MA, Weinberg J, Turner A, Ray P, Holick MF (2002) Bone mineral density assessment: comparison of dual-energy X-ray absorptiometry measurements at the calcaneus, spine, and hip. J Clin Densitom 5:57–62CrossRefPubMed
35.
go back to reference Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229CrossRefPubMed Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229CrossRefPubMed
Metadata
Title
Genetic Polymorphisms of OPG, RANK, and ESR1 and Bone Mineral Density in Korean Postmenopausal Women
Authors
J. Y. Choi
A. Shin
S. K. Park
H. W. Chung
S.I. Cho
C. S. Shin
H. Kim
K. M. Lee
K. H. Lee
C. Kang
D. Y. Cho
D. Kang
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 3/2005
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-004-0264-0

Other articles of this Issue 3/2005

Calcified Tissue International 3/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.